×
About 2,173 results

ALLMedicine™ Tourette Syndrome Center

Research & Reviews  751 results

Evaluate the Efficacy, Safety and Tolerability of TSUPPORT for Adults With Tourette Syndrome
https://clinicaltrials.gov/ct2/show/NCT05183594

Jan 11th, 2022 - This study is to evaluate the efficacy, safety and tolerability of TSupport (a Traditional Chinese Medicine) for adults with Tourette Syndrome, which consists of a screening/wash-out period of up to 6 weeks, a 24-week supportive care period and a ...

Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cells for Tourette Syndrome
https://clinicaltrials.gov/ct2/show/NCT05158439

Jan 5th, 2022 - This patient funded trial aims to study the safety and efficacy of intravenous infusion of cultured allogeneic adult umbilical cord derived mesenchymal stem cells (UC-MSCs) for the treatment of Tourette Syndrome. Patients will receive a single int...

Tourette Syndrome Deep Brain Stimulation
https://clinicaltrials.gov/ct2/show/NCT02056873

Dec 22nd, 2021 - Normal clinical care for TS includes cognitive behavior therapy, medication, supportive psychotherapy, and/or a combination of the two. To meet entry criteria for this study, you must have already tried these methods and they did not help your sym...

Frequency and Intensity of Premonitory Urges-to-Tic in Tourette Syndrome Is Associated ...
https://doi.org/10.1002/mds.28868
Movement Disorders : Official Journal of the Movement Dis... He JL, Mikkelsen M et. al.

Dec 3rd, 2021 - Individuals with Tourette syndrome (TS) often report that they express tics as a means of alleviating the experience of unpleasant sensations. These sensations are perceived as an urge to act and are referred to as premonitory urges. Premonitory u...

Endocannabinoid Modulation Using Monoacylglycerol Lipase Inhibition in Tourette Syndrom...
https://doi.org/10.1055/a-1675-3494
Pharmacopsychiatry Müller-Vahl KR, Fremer C et. al.

Dec 1st, 2021 - Tourette syndrome (TS) is a complex neurodevelopmental disorder characterized by chronic motor and vocal tics. While consistently effective treatment is lacking, evidence indicates that the modulation of endocannabinoid system is potentially benef...

see more →

Guidelines  3 results

European clinical guidelines for Tourette syndrome and other tic disorders. Part I: ass...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3065640
European Child & Adolescent Psychiatry; Cath DC, Hedderly T et. al.

Mar 30th, 2011 - A working group of the European Society for the Study of Tourette Syndrome (ESSTS) has developed the first European assessment guidelines of Tourette Syndrome (TS). The available literature including national guidelines was thoroughly screened and...

European clinical guidelines for Tourette syndrome and other tic disorders. Part III: b...
https://doi.org/10.1007/s00787-011-0167-3
European Child & Adolescent Psychiatry; Verdellen C, van de Griendt J et. al.

Mar 30th, 2011 - This clinical guideline provides recommendations for the behavioural and psychosocial interventions (BPI) of children and adolescents with tic disorders prepared by a working group of the European Society for the Study of Tourette Syndrome (ESSTS)...

European clinical guidelines for Tourette syndrome and other tic disorders. Part II: ph...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3065650
European Child & Adolescent Psychiatry; Roessner V, Plessen KJ et. al.

Mar 30th, 2011 - To develop a European guideline on pharmacologic treatment of Tourette syndrome (TS) the available literature was thoroughly screened and extensively discussed by a working group of the European Society for the Study of Tourette syndrome (ESSTS). ...

see more →

Clinicaltrials.gov  39 results

Evaluate the Efficacy, Safety and Tolerability of TSUPPORT for Adults With Tourette Syndrome
https://clinicaltrials.gov/ct2/show/NCT05183594

Jan 11th, 2022 - This study is to evaluate the efficacy, safety and tolerability of TSupport (a Traditional Chinese Medicine) for adults with Tourette Syndrome, which consists of a screening/wash-out period of up to 6 weeks, a 24-week supportive care period and a ...

Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cells for Tourette Syndrome
https://clinicaltrials.gov/ct2/show/NCT05158439

Jan 5th, 2022 - This patient funded trial aims to study the safety and efficacy of intravenous infusion of cultured allogeneic adult umbilical cord derived mesenchymal stem cells (UC-MSCs) for the treatment of Tourette Syndrome. Patients will receive a single int...

Tourette Syndrome Deep Brain Stimulation
https://clinicaltrials.gov/ct2/show/NCT02056873

Dec 22nd, 2021 - Normal clinical care for TS includes cognitive behavior therapy, medication, supportive psychotherapy, and/or a combination of the two. To meet entry criteria for this study, you must have already tried these methods and they did not help your sym...

Ecopipam Tablets to Study Tourette Syndrome in Children and Adolescents - Open Label Extension
https://clinicaltrials.gov/ct2/show/NCT04114539

Nov 26th, 2021 - This is an international, multicenter, open-label, long term extension study evaluating the safety of ecopipam tablets for the treatment of pediatric subjects (aged ≥6 to ≤18 years at Baseline) with Tourette Syndrome. Subjects who completed the Ph...

SCI-110 in the Treatment of Tourette Syndrome
https://clinicaltrials.gov/ct2/show/NCT05126888

Nov 19th, 2021 - It is believed that SCI-110 will be a valuable treatment option, especially for t those subjects with TS, who do not benefit from or do not tolerate first-line treatment with antipsychotics. Since there is evidence that currently available CBM imp...

see more →

News  72 results

Tourette Syndrome
https://tools.cdc.gov/medialibrary/index.aspx#/media/id/427457

Tourette syndrome causes people to have tics. Tics are sudden twitches, movements, or sounds that people do repeatedly, such as blinking repeatedly or making a grunting sound.

Surge in New-Onset Tics in Adults Tied to COVID-19 Stress
https://www.medscape.com/viewarticle/959190

Sep 21st, 2021 - Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. An unusual surge of new-onset tics in patients with no prior history of these disorders, has been tied to the psychological stress associated with...

Early Data for Experimental THC Drug 'Promising' for Tourette's
https://www.medscape.com/viewarticle/956984

Aug 20th, 2021 - Oral delta-9-tetrahydracannabinol (Δ9-THC) and palmitoylethanolamide (PEA), in a proprietary combination known as THX-110, is promising for reducing tic symptoms in adults with Tourette syndrome (TS), new research suggests. In a small phase 2 tria...

Back to Normal? For Many Physicians, the Answer Is 'Not So Fast…'
https://www.medscape.com/viewarticle/953967

Jul 2nd, 2021 - As the pandemic restrictions are being lifted and life is increasingly getting "back to normal," not everyone is ready. Many workers, asked to come back to the office and often facing long commutes again, are looking for greater flexibility or are...

Going Viral: Social Media May Be Increasing Cases of New-Onset Tics
https://www.medscape.com/viewarticle/949882

May 6th, 2021 - This transcript has been edited for clarity. Kathrin LaFaver, MD: Hello. I'm Dr Kathrin LaFaver, a movement disorders specialist at Northwestern University here in Chicago. It is my great pleasure today to interview Dr Tamara Pringsheim on the top...

see more →

Patient Education  4 results see all →